About MEAJO | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions to authors | Online submission | Subscribe | Advertise | Contact | Login 
Middle East African Journal of Ophthalmology Middle East African Journal of Ophthalmology
Users Online: 342   Home Print this page Email this page Small font sizeDefault font sizeIncrease font size

    Article Cited by others

UPDATES IN CLINICAL TRIALS IN RETINA

Update on clinical trials in dry Age-related macular degeneration

Taskintuna Ibrahim, Elsayed M.E. A. Abdalla, Schatz Patrik

Year : 2016| Volume: 23| Issue : 1 | Page no: 13-26

   This article has been cited by
 
1 Platelet Lysate as a Promising Medium for Nanocarriers in the Management and Treatment of Ocular Diseases
S. Balaji, R. Karthikeyan, V. Kiran, B. Yuvaraj, Saraswathi Nagaraj, Sivakami Manivannan, Shoba Narayan
Current Ophthalmology Reports. 2022;
[Pubmed]  [Google Scholar] [DOI]
2 Evolution of oxidative stress, inflammation and neovascularization in the choroid and retina in a subretinal lipid induced age-related macular degeneration model
Soo-Young Kim, Siva P. Kambhampati, Imran A. Bhutto, D. Scott McLeod, Gerard A. Lutty, Rangaramanujam M. Kannan
Experimental Eye Research. 2021; 203: 108391
[Pubmed]  [Google Scholar] [DOI]
3 Subretinal Rather Than Intravitreal Adeno-Associated Virus–Mediated Delivery of a Complement Alternative Pathway Inhibitor Is Effective in a Mouse Model of RPE Damage
Balasubramaniam Annamalai, Nathaniel Parsons, Crystal Nicholson, Elisabeth Obert, Bryan Jones, Bärbel Rohrer
Investigative Opthalmology & Visual Science. 2021; 62(4): 11
[Pubmed]  [Google Scholar] [DOI]
4 Cellular senescence in the aging retina and developments of senotherapies for age-related macular degeneration
Keng Siang Lee, Shuxiao Lin, David A. Copland, Andrew D. Dick, Jian Liu
Journal of Neuroinflammation. 2021; 18(1)
[Pubmed]  [Google Scholar] [DOI]
5 Progress in the Treatment of Dry Age-Related Macular Degeneration
?? ?
Advances in Clinical Medicine. 2020; 10(05): 849
[Pubmed]  [Google Scholar] [DOI]
6 Ocular Disease Therapeutics: Design and Delivery of Drugs for Diseases of the Eye
Kuei-Ju Cheng, Chien-Ming Hsieh, Kunal Nepali, Jing-Ping Liou
Journal of Medicinal Chemistry. 2020; 63(19): 10533
[Pubmed]  [Google Scholar] [DOI]
7 A Semiautomated, Phenotypic, In Vitro Scratch Assay for Assessing Retinal Pigment Epithelial Cell Wound Healing
Tina Storm, Iain Wilson, Ross Campbell, Arantxa Bolinches-Amorós, Angela J. Russell, Stephen G. Davies, Alun R. Barnard, Robert E. MacLaren
Journal of Ocular Pharmacology and Therapeutics. 2020; 36(4): 257
[Pubmed]  [Google Scholar] [DOI]
8 A Novel Eye Drop Candidate for Age-Related Macular Degeneration Treatment: Studies on its Pharmacokinetics and Distribution in Rats and Rabbits
Eun-Jeong Choi, Go-Wun Choi, Ju Hee Kim, Hee-Woon Jang, Ju-Hee Lee, Hyun Ju Bae, Young Gwan Kim, Yong-Bok Lee, Hea-Young Cho
Molecules. 2020; 25(3): 663
[Pubmed]  [Google Scholar] [DOI]
9 Ocular Carotenoid Status in Health and Disease
Lydia Sauer, Binxing Li, Paul S. Bernstein
Annual Review of Nutrition. 2019; 39(1): 95
[Pubmed]  [Google Scholar] [DOI]
10 Changing vision: a review of pharmacogenetic studies for treatment response in age-related macular degeneration patients
Janan Arslan, Paul N Baird
Pharmacogenomics. 2018; 19(5): 435
[Pubmed]  [Google Scholar] [DOI]
11 Lessons from Anti-Amyloid-ß Immunotherapies in Alzheimer Disease: Aiming at a Moving Target
Youmei Wang, Tao Yan, Honghui Lu, Weiming Yin, Bin Lin, Weibin Fan, Xiaoli Zhang, Pedro Fernandez-Funez
Neurodegenerative Diseases. 2017; 17(6): 242
[Pubmed]  [Google Scholar] [DOI]

 

Read this article